MedTrace Logo

INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP

NCT03547297 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 212

Last updated 2019-01-25

No results posted yet for this study

Summary

This study will use specific diagnostic tests on a group of patients who are experiencing symptoms typical of acute hepatic porphyria (AHP) to determine how many have the condition, and to potentially help improve the diagnostic process for patients in the future.

Conditions

  • Acute Hepatic Porphyria
  • Hepatic Porphyrias
  • Acute Intermittent Porphyria (AIP)
  • Hereditary Coproporphyria (HCP)
  • Variegate Porphyria (VP)
  • ALA Dehydratase Deficient Porphyria (ADP)
  • Porphyria Acute

Sponsors & Collaborators

Principal Investigators

  • Quinn Dinh, MD · Alnylam Pharmaceuticals

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-29
Primary Completion
2019-01-15
Completion
2019-01-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547297 on ClinicalTrials.gov